Min MS - Search Results

1

Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers.

Min MS, Alsarheed A, Kassamali B, Mazori DR, Schaefer M, Merola JF, Cobos G, LaChance AH, Vleugels RA. Min MS, et al. J Am Acad Dermatol. 2022 Feb;86(2):423-425. doi: 10.1016/j.jaad.2021.07.003. Epub 2021 Jul 8. J Am Acad Dermatol. 2022. PMID: 34246697 No abstract available.

2

Treatment of recalcitrant granuloma annulare (GA) with adalimumab: A single-center, observational study.

Min MS, Lebwohl M. Min MS, et al. J Am Acad Dermatol. 2016 Jan;74(1):127-33. doi: 10.1016/j.jaad.2015.09.015. Epub 2015 Nov 6. J Am Acad Dermatol. 2016. PMID: 26552891

3

Overview of TikTok's most viewed dermatologic content and assessment of its reliability.

Villa-Ruiz C, Kassamali B, Mazori DR, Min M, Cobos G, LaChance A. Villa-Ruiz C, et al. J Am Acad Dermatol. 2021 Jul;85(1):273-274. doi: 10.1016/j.jaad.2020.12.028. Epub 2020 Dec 25. J Am Acad Dermatol. 2021. PMID: 33359080 No abstract available.

4

Characterizing top educational TikTok videos by dermatologists in response to "TikTok and dermatology: An opportunity for public health engagement".

Kassamali B, Villa-Ruiz C, Mazori DR, Min M, Cobos GA, LaChance AH. Kassamali B, et al. J Am Acad Dermatol. 2021 Jul;85(1):e27-e28. doi: 10.1016/j.jaad.2021.02.051. Epub 2021 Feb 26. J Am Acad Dermatol. 2021. PMID: 33647380 No abstract available.

5

Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort.

Ghatnekar S, Shah N, Min MS, Mazori DR, LaChance AH, Vleugels RA, Nambudiri VE. Ghatnekar S, et al. Among authors: min ms. J Am Acad Dermatol. 2022 Apr;86(4):907-909. doi: 10.1016/j.jaad.2021.03.043. Epub 2021 Mar 24. J Am Acad Dermatol. 2022. PMID: 33771592 No abstract available.

6

The catch-22 of limited Food and Drug Administration approval for connective tissue disease therapies.

Min MS, Kassamali B, Mazori DR, Vleugels RA, Merola JF, Cobos G, LaChance AH. Min MS, et al. J Am Acad Dermatol. 2021 Aug;85(2):517-519. doi: 10.1016/j.jaad.2021.03.103. Epub 2021 Apr 3. J Am Acad Dermatol. 2021. PMID: 33823201 No abstract available.

7

Lack of association between tumor necrosis factor-α inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort study.

Min MS, Kassamali B, Mazori DR, Gizelis O, Schaefer M, Ho A, Merola JF, Cobos G, LaChance AH, Vleugels RA. Min MS, et al. J Am Acad Dermatol. 2022 May;86(5):1180-1182. doi: 10.1016/j.jaad.2021.04.083. Epub 2021 Apr 30. J Am Acad Dermatol. 2022. PMID: 33940099 No abstract available.

8

Use of Tofacitinib, 2%, Ointment for Periorbital Discoid Lupus Erythematosus.

Mazori DR, Min MS, Kassamali B, Brichta L, Merola JF, Vleugels RA, LaChance AH. Mazori DR, et al. Among authors: min ms. JAMA Dermatol. 2021 Jul 1;157(7):880-882. doi: 10.1001/jamadermatol.2021.1198. JAMA Dermatol. 2021. PMID: 34076672 No abstract available.

9

Importance of nose wires in face masks: A reply to "Diagnostic and management considerations for "maskne" in the era of COVID-19".

Kassamali B, Kus KJB, Min MS, Cobos GA, LaChance AH, Mazori DR. Kassamali B, et al. Among authors: min ms. J Am Acad Dermatol. 2021 Sep;85(3):e151-e152. doi: 10.1016/j.jaad.2021.04.101. Epub 2021 Jun 5. J Am Acad Dermatol. 2021. PMID: 34102251 Free PMC article. No abstract available.

10

Bright Red Macules of the Lower Legs.

O'Connell KA, Min MS, LaChance AH. O'Connell KA, et al. Among authors: min ms. JAMA Dermatol. 2021 Sep 1;157(9):1118-1119. doi: 10.1001/jamadermatol.2021.2980. JAMA Dermatol. 2021. PMID: 34379076 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters